Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer
about
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesTrends in biomedical informatics: automated topic analysis of JAMIA articlesA priori Prediction of Neoadjuvant Chemotherapy Response and Survival in Breast Cancer Patients using Quantitative UltrasoundUsing computer-extracted image phenotypes from tumors on breast magnetic resonance imaging to predict breast cancer pathologic stage.US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI.Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasisEvaluation of Soft Tissue Sarcoma Response to Preoperative Chemoradiotherapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy ResponsePredicting breast cancer response to neoadjuvant chemotherapy using pretreatment diffuse optical spectroscopic texture analysis.Application of Texture Analysis to Study Small Vessel Disease and Blood-Brain Barrier Integrity.Biomedical imaging informatics in the era of precision medicine: progress, challenges, and opportunities.Assessing treatment response in triple-negative breast cancer from quantitative image analysis in perfusion magnetic resonance imaging.Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT/VMAT.2,3,5,4‑tetrahydroxy diphenylethylene‑2‑O‑glucoside inhibits the adhesion and invasion of A549 human lung cancer cells.Early detection of chemotherapy-refractory patients by monitoring textural alterations in diffuse optical spectroscopic images.MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.
P2860
Q26774810-1C29EC39-7EA1-46FE-8208-A5E54AA0BB91Q28596404-89F1A5A7-0EBA-4DF7-84FE-49CF19EA9CEAQ30358741-6A869C5F-80C2-449F-9CF4-67B0AA5E5032Q35855936-C5B56C0E-E929-4D70-BBAE-F38CF5870AC6Q35911336-4315932D-E0D1-4BA1-B8D2-60E6EEEB063AQ35947118-C9CA27FC-ABC9-4B9E-B97B-580F1E297A99Q37245527-5B102E81-2435-44C6-A1D8-BBF9067CBBACQ37561844-1D11E451-C8B2-48B8-AA34-076D9D286ABFQ38687135-550FAE8B-7E87-415E-9BF5-442AEE2DFA0BQ38832422-5702145D-E9D7-44C7-A09A-97A69897B3B9Q40109121-F9415E50-77D0-41CD-849D-143404C9A7C0Q42915609-E7B1F681-9E0E-4743-9C70-736572DE29D8Q45943928-9F3C45F3-99DC-4599-A223-3B59073062A9Q46615143-7090CFC6-07E1-43A9-873A-137651E5E888Q47679730-4D998AE2-43A5-4F2D-BA7B-357E23AFB602Q50782447-6784C548-F005-4BBB-88AA-F35840ED925AQ55361006-C97C3CCC-4E2F-4619-A55D-5AACC9A13106
P2860
Dynamic contrast-enhanced MRI-based biomarkers of therapeutic response in triple-negative breast cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer
@en
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer.
@nl
type
label
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer
@en
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer.
@nl
prefLabel
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer
@en
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer.
@nl
P2093
P2860
P1476
Dynamic contrast-enhanced MRI- ...... triple-negative breast cancer
@en
P2093
Daniel I Golden
Daniel L Rubin
Jafi A Lipson
Melinda L Telli
P2860
P304
P356
10.1136/AMIAJNL-2012-001460
P50
P577
2013-06-19T00:00:00Z